Helix Biopharma Corp. HBP.TO
TSX
| 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -490.20K | -500.50K | -726.40K | -691.50K | -1.09M |
| Total Depreciation and Amortization | 0.00 | 700.00 | 1.40K | 700.00 | 2.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.60K | 5.80K | 64.90K | 33.50K | 40.80K |
| Change in Net Operating Assets | -124.00K | 165.20K | -220.50K | 184.90K | 71.80K |
| Cash from Operations | -628.80K | -328.90K | -880.60K | -472.40K | -971.60K |
| Capital Expenditure | -- | -- | -- | 0.00 | 0.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 0.00 |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 0.00 | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 3.67M | -- | 1.66M | -- | 100.00K |
| Repurchase of Common Stock | -- | -11.00K | -- | -1.00K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.68M | -7.90K | 1.19M | -700.00 | 70.40K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.05M | -336.80K | 312.00K | -473.10K | -901.30K |